Same Indication

Metronidazole vs Pembrolizumab

Metronidazole vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Metronidazole and Pembrolizumab.

Mechanism of Action

Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Metronidazole — 8 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Metronidazole — C6H9N3O3.

Molecular Weight: Metronidazole — 171.1540 g/mol.

Type: Metronidazole — Small molecule; Pembrolizumab — Antibody.